martes, 7 de enero de 2014

Speaking of Sanofi

Sanofi US has branched out in its blogging efforts and this week launched Speaking of Sanofi, its first corporate blog.

Managed by the company's corporate reputation and digital communications director Stacy Burch, the blog will include perspectives from Sanofi companies like its vaccine arm Sanofi Pasteur, biotech business Genzyme and animal health company Merial.
Alhough it's still early days for the blog, Sanofi already has an impressive list of contributors planned for Speaking of Sanofi.
These include the head of its North America R&D Hub Marc Bonnefoi, SVP of commercial operations at Sanofi Pasteur Damian Braga and CEO of Genzyme David Meeker.
Outlining Sanofi's plans in an introductory post Burch said Sanofi would also be inviting industry leaders to contribute guest posts.
The new blog adds to the Discuss Diabetes blog Sanofi launched in January 2011 and is further evidence of a resurgence of industry interest in the medium.
The time required to run a blog, certainly when compared with 'lighter' options -at least in terms of writing - like Twitter, has tended to keep their numbers down.
But this year has seen a higher than average number of pharma companies begin blogs, from AstraZeneca's Lab Talk and Lilly's expansion of its LillyPad blog, to Bayer UK's Diabetes Care blog and Boehringer Ingelheim's plans for The Future Just Happened.
PERSONAL COMMENT

Sanofi corporate communication efforts are once again highlighted by their new brand release. The multinational, leader on its sector in terms of external communication, has previous experience in this blog world. There is no doubt Sanofi knows how to engaged stronger relationhisps with its customers, reinforcing the contact and making it special and different from the competence.

Nowadays, with the huge increase of competence and the strong necessity of making the difference, it is extremely important for the companies to realize about the incredible benefits that social media and external communication bring to a company.

Opening a blog is a chance to publish not only the company discoveries and latest news but also interesting posts that catch customer’s attention or even collaborate with other firms in the industry, showing it to the world in just seconds. This is show Sanofi is working, appreciating the power of the new sites that make the firm visible worldwide, which is completely essential whn being a multinational.

The firm is doing a great job, after having made the difference with its work on the Diabetes field, opening a blog, launching a forum, and creating Twitter and Facebook profiles, through which it can mantain  direct contact with its patients. Now, with its new corporate blog, the company keeps on the correct direction to stand out from the crowd, taking the maximum benefit from the unlimited chances new communication model brings nowadays.

Itziar Barbón Carcedo

No hay comentarios:

Publicar un comentario